Skip to Content
Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Inyx Inc is focused on the development, manufacture and marketing of prescription and over-the-counter aerosol products and drug delivery technologies for the treatment of respiratory, allergy, cardiovascular and dermatological and topical conditions.

Contact
825 3rd Avenue, 21st Floor
New York, NY, 10022
T +1 212 838-1111
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2006
Fiscal Year End Dec 31, 2012
Stock Type Distressed
Employees 572